{"ticker": {"uuid": "3e0280e3-34eb-4a76-aafb-d7d2fcbd4256", "symbol": "IRMD", "name": "Iradimed Co", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Should You Think About Buying IRADIMED CORPORATION (NASDAQ:IRMD) Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQdmVmRTBxQ0Q5M1p3YkVXaUxONU9nNDQ0QVhQMnJyS3NOS2tWdF9aTFVod2RjMHBPZHhhelBybjUyRlJ0TVFCMmJXOVFEbmZZYWJza3lRX1k2Y1d0TGl3a0ZzMjRPZ3dJMXJyMHdOZ09pbmhKa05pM3lGX0dwdDFkRDkyamJQc0pfd0h3bGFFMnFvWUpmaHdjZnRxTDJlX1NYT0RhWmlpZU1HTGtu?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T12:26:37+00:00", "published_display": "13 Jul 2026 12:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision Trading with Iradimed Corporation (IRMD) Risk Zones", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOQXhqaFBMMk1iVmRkQnRVRDBibkRsWWpib1BkM2MzZUpaYmVVc1JiOGw5dTBIWF9xZWN0V3hnZHRZSUdnOFZqUVV0dmVnMmhySTRCUC1yYWFhZDJNOWpreVg3cGlVSXpDLVJzM2xNa1FjazlGUmszR2pqWTQ0UG9nLTh5YkNFLXZ0WlR6SFZfSUo1WjZPaWxjUzRvS0Y5Yk15TDIwYnFuSnloNjlSUVNFS0ktVVlkNGR0bnFkTXBKRUUzSjJhRmNMbVRNWnVTYnpFRF9JM0dB?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-07-08T06:38:01+00:00", "published_display": "08 Jul 2026 06:38", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of iRadimed Corporation \u2013 NASDAQ:IRMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNYy1NNFhnWVFWd1drYXVjcUU1Yk5qc2pQV3hSM1BnUjRzYldsdVhlVDhmOW81RlppcUE3VUdVVUdJSElRSWtxTHMtZGF5VFdLZkNKd0FJSDhtb0o2QmhLR2ZJOEpka1Nlc1VKdElEcTI0NkdVTjQ1MlZtNmN4SGw5X1N0OFNjdEtVRVZmUl9hd1BkOXBRMFk1eHBvblc?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T09:35:02+00:00", "published_display": "05 Jul 2026 09:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of IRadimed Corp. \u2013 LS:A118V4", "summary": "This article provides financial information for IRadimed Corp. (LS:A118V4), specifically focusing on its price-to-book forward ratio. It includes an overview of the company's financials on TradingView, such as market data provided by ICE Data Services and reference data from Fact", "url": "https://www.tradingview.com/symbols/LS-A118V4/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T09:10:28", "published_display": "05 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD - Iradimed Corp Latest SEC Filings", "summary": "This article provides the latest SEC filings and a comprehensive overview of Iradimed Corp (IRMD) financials and performance metrics. It details key financial figures such as market cap, income, sales, and various ratios, alongside stock performance, insider and institutional own", "url": "https://finviz.com/stock?t=IRMD&p=d&ty=lf&r=ytd&page=15", "source_name": "Finviz", "published_at": "2026-06-30T13:40:00", "published_display": "30 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of IRadimed Corp. \u2013 HAN:46K", "summary": "This article provides the \"Price to book forward\" metric for IRadimed Corp. (HAN:46K) trading on the Hannover Stock Exchange. It is a financial data point without further analysis or contextual information.", "url": "https://www.tradingview.com/symbols/HAN-46K/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T04:41:31", "published_display": "29 Jun 2026 04:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of IRadimed Corp. \u2013 HAN:46K", "summary": "This article presents the enterprise value to revenue forward for IRadimed Corp. (HAN:46K) as listed on the Hannover Stock Exchange. Although the article provides no specific numerical data, it frames the company's financial metric within the context of a stock exchange listing. ", "url": "https://www.tradingview.com/symbols/HAN-46K/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T13:39:36", "published_display": "28 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp. Actuals & Estimates (DUS:46K)", "summary": "This article provides an overview of IRadimed Corp. (DUS:46K) financial actuals and estimates, including income statement, balance sheet, and cash flow data. It covers analyst forecasts for the stock, historical price performance, upcoming earnings dates, and details on past earn", "url": "https://www.tradingview.com/symbols/DUS-46K/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-28T10:10:59", "published_display": "28 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "46K Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for IRadimed Corp. (46K) stock, based on analyst opinions. It includes details on maximum and minimum price estimates, past financial performance, upcoming earnings dates, dividend information, and company metrics like EBITDA and ", "url": "https://www.tradingview.com/symbols/FWB-46K/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T11:39:32", "published_display": "26 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp. Actuals & Estimates (NASDAQ:IRMD)", "summary": "This article provides an overview of iRadimed Corporation (NASDAQ: IRMD) including financial actuals, estimates, and analyst forecasts. It covers key metrics like current stock price, historical highs and lows, market capitalization, earnings, revenue, dividends, and volatility, ", "url": "https://www.tradingview.com/symbols/NASDAQ-IRMD/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:10:14", "published_display": "26 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed (NASDAQ: IRMD) investors approve directors, auditor and pay", "summary": "Iradimed Corporation's shareholders held their annual meeting, where they elected Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel, and James Hawkins to the board of directors. They also approved RSM US LLP as the independent auditor for the fiscal year ending December 31", "url": "https://www.stocktitan.net/sec-filings/IRMD/8-k-iradimed-corp-reports-material-event-44ff5640cf4a.html", "source_name": "Stock Titan", "published_at": "2026-06-24T14:39:52", "published_display": "24 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Iradimed Co For: 23 June By Investing.com", "summary": "This article from Investing.com is a regulatory filing update titled \"Form 4 Iradimed Co For: 23 June.\" It reports on the Form 4 filing for Iradimed Co (IRMD) made on June 23rd, 2026, indicating insider transactions for the company. The article contains the title, publication dat", "url": "https://au.investing.com/news/stock-market-news/form-4-iradimed-co-for-23-june-93CH-4500543", "source_name": "Investing.com Australia", "published_at": "2026-06-23T23:09:32", "published_display": "23 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED (IRMD) CFO converts RSUs to stock and uses 2,319 shares for taxes", "summary": "IRADIMED CFO John Glenn converted 5,796 restricted stock units (RSUs) into common shares on June 20, 2026. He then disposed of 2,319 shares to cover tax obligations, which was a tax-withholding transaction, not an open-market sale. Following these transactions, Glenn directly hol", "url": "https://www.stocktitan.net/sec-filings/IRMD/form-4-iradimed-corp-insider-trading-activity-165cd58b1d27.html", "source_name": "Stock Titan", "published_at": "2026-06-23T13:10:26", "published_display": "23 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED (IRMD) Stock Could Be 21.9% Undervalued on Its MRI Pump Upgrade Narrative", "summary": "IRADIMED (IRMD) is currently valued by one narrative as 21.9% undervalued at $92.20 per share, with a fair value target of $118, primarily due to the anticipated replacement cycle driven by its new 3870 MRI compatible IV pump. While this narrative projects significant revenue gro", "url": "https://www.sahmcapital.com/news/content/iradimed-irmd-stock-could-be-219-undervalued-on-its-mri-pump-upgrade-narrative-2026-06-22", "source_name": "Sahm", "published_at": "2026-06-22T00:10:04", "published_display": "22 Jun 2026 00:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD Technical Analysis & Stock Price Forecast", "summary": "The article provides a technical analysis and stock price forecast for IRadimed Corp (IRMD), indicating a \"Strong Buy\" consensus based on various technical indicators and moving averages. While some indicators like RSI are neutral or sell, the MACD and several moving averages sug", "url": "https://intellectia.ai/en/stock/IRMD/technical", "source_name": "Intellectia AI", "published_at": "2026-06-18T21:13:19", "published_display": "18 Jun 2026 21:13", "sentiment": "positive", "sentiment_pct": 76, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for IRadimed Corp (IRMD), indicating an earnings forecast score of 8.00 and ranking 66th in its industry. Analysts, based on 2 ratings, have an average price target of $99.00 with a \"Buy\" recommendation. The company's previous quarter EP", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T20:11:16", "published_display": "18 Jun 2026 20:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for IRadimed Corp (IRMD), highlighting its current risk assessment score of 7.77 and ranking within the Healthcare Equipment & Supplies industry. It details various risk metrics including beta, maximum drawdown, volatility, and Sharpe Ratio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-17T21:40:51", "published_display": "17 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides a detailed historical overview of IRadimed Corp's (IRMD) dividend payouts, including future declared dividends. It lists the dividend amount, record date, payment date, and ex-dividend date for various interim and final cash dividends. The report also notes ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T20:11:16", "published_display": "17 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of IRadimed Corp (IRMD), listing major individual and institutional holders. It provides a breakdown of shareholder types and traces institutional shareholding trends over several quarters. The data includes the proportion of shares ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T02:11:13", "published_display": "17 Jun 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for IRadimed Corp (IRMD), categorizing its revenue by business segments and geographical regions. As of April 6, 2024, the company's largest revenue contributors are MRI Compatible IV Infusion Pump Systems and MRI Compatible Pati", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T02:11:12", "published_display": "17 Jun 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Institutional Confidence", "summary": "IRadimed Corp (IRMD) has an institutional shareholding score of 5.00, placing it 109th in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 65.08%, a 13.11% increase quarter-over-quarter. James Simons is the largest institutional sharehold", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/sentiment", "source_name": "TradingKey", "published_at": "2026-06-16T20:09:14", "published_display": "16 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of IRadimed Corp (IRMD), focusing on its support and resistance levels, various technical indicators, and moving averages. As of June 16, 2026, IRMD's price momentum score is 7.36, and the stock is trading between resistance at $98.06 an", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/technical", "source_name": "TradingKey", "published_at": "2026-06-16T19:40:26", "published_display": "16 Jun 2026 19:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article provides a financial analysis of IRadimed Corp (IRMD), highlighting its strong financial health with a score of 9.60. The company ranks highly in its industry due to robust financial status, high operating efficiency, and significant year-over-year increases in reven", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-16T07:40:51", "published_display": "16 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Number of shareholders of IRadimed Corp. \u2013 DUS:46K", "summary": "The article displays an overview of IRadimed Corp. (DUS:46K) on the TradingView platform, focusing on the number of shareholders. It includes sections for financial data, news, community insights, forecasts, and stock information, indicating a market closed status with no recent ", "url": "https://www.tradingview.com/symbols/DUS-46K/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-06-06T23:09:43", "published_display": "06 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD - Iradimed Corp Stock Price and Quote", "summary": "This page provides a comprehensive overview of Iradimed Corp (IRMD) stock, including its latest closing price, dollar and percentage changes, and various financial metrics such as market cap, income, sales, and P/E ratio. It also details dividend information, employee count, IPO ", "url": "https://finviz.com/stock?t=IRMD", "source_name": "Finviz", "published_at": "2026-06-05T15:10:28", "published_display": "05 Jun 2026 15:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed director sells $285,000 in company stock By Investing.com", "summary": "A director at IRADIMED CORP, Hilda Frederique Scharen-Guivel, sold 3,000 shares of company stock for $285,000 on June 4, 2026. This transaction occurred amidst a strong 52% return for IRMD stock over the past year, though InvestingPro's Fair Value analysis suggests the shares may", "url": "https://za.investing.com/news/insider-trading-news/iradimed-director-sells-285000-in-company-stock-93CH-4315160", "source_name": "Investing.com South Africa", "published_at": "2026-06-05T04:40:10", "published_display": "05 Jun 2026 04:40", "sentiment": "negative", "sentiment_pct": 33, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Hilda Scharen-guivel Sells 3,000 Shares of iRadimed Corp (IRMD)", "summary": "Hilda Scharen-guivel, a Director at iRadimed Corp (IRMD), sold 3,000 shares of the company on June 4, 2026, reducing her holdings to 5,598 shares. This sale contributes to a pattern of 41 insider sells and no buys over the past year. iRadimed Corp, trading at $95 per share, is co", "url": "https://www.gurufocus.com/news/8902377/insider-sell-hilda-scharenguivel-sells-3000-shares-of-iradimed-corp-irmd?mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-05T03:09:43", "published_display": "05 Jun 2026 03:09", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed Insider Sold Shares Worth $285,000, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iradimed-insider-sold-shares-worth-203258087.html", "source_name": "MT Newswires", "published_at": "2026-06-04T20:32:58+00:00", "published_display": "04 Jun 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED (IRMD) director sells 3,000 shares in open-market trades", "summary": "IRADIMED CORP director Hilda Frederique Scharen-Guivel sold 3,000 shares of Common Stock in open-market transactions for $95.00 per share on June 4, 2026. This transaction represents a net sale of $285,000 and is categorized as negative filing sentiment. The shares she still hold", "url": "https://www.stocktitan.net/sec-filings/IRMD/form-4-iradimed-corp-insider-trading-activity-9144089377e9.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:10:03", "published_display": "04 Jun 2026 20:10", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD (NASDAQ: IRMD) files notice to resell 285,000 common shares", "summary": "Iradimed Corp (IRMD) has filed a Form 144 notice with the SEC, indicating a proposed sale of 285,000 shares of common stock. The filing also notes that 12,783,035 shares were outstanding as of June 4, 2026, and references RSU vesting events in 2023 and 2024. This form serves as a", "url": "https://www.stocktitan.net/sec-filings/IRMD/144-iradimed-corp-sec-filing-49e31ce5f132.html", "source_name": "Stock Titan", "published_at": "2026-06-04T17:10:03", "published_display": "04 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOS1ZEUlNmRDFyOFZma2NzQk1Sa1VaSk43a2xZOTRQNl9FT3o1OWhtRXQzWHpyVzZSaTFVeUF0eXpJMXZGOU8xbmtIUC14SGRTemhHM0F4aXdWclBqT012ZHRFMkJkcmRjWHJBcVFCczR1WTc1M1NHeDZGWEdMVHQ0YmlMZGZFWTJiTWxlU1hVekFTQ2tubUQtd3FrX25UVDlpVnBDc3dKTXY?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares", "summary": "IRADIMED CORP (NASDAQ:IRMD) CEO Roger E. Susi sold 2,500 shares of common stock totaling $226,507 on June 1, 2026, through the Phillip Susi 2008 Dynasty Trust under a Rule 10b5-1 trading plan. These sales occurred after a strong 61.5% return for IRMD stock and follow the company'", "url": "https://m.investing.com/news/insider-trading-news/iradimed-corp-ceo-roger-susi-sells-226507-in-irmd-shares-93CH-4722722?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-02T18:39:54", "published_display": "02 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED (IRMD) CEO-linked trust sells 2,500 shares under 10b5-1 plan", "summary": "A trust linked to Roger E. Susi, CEO of IRADIMED (IRMD), indirectly sold 2,500 shares of common stock on June 1, 2026, under a pre-arranged Rule 10b5-1 trading plan. The shares were sold in multiple trades at weighted average prices between $88.68 and $91.91. After these transact", "url": "https://www.stocktitan.net/sec-filings/IRMD/form-4-iradimed-corp-insider-trading-activity-4269a0755465.html", "source_name": "Stock Titan", "published_at": "2026-06-02T18:39:54", "published_display": "02 Jun 2026 18:39", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED's CEO Is Selling Steadily \u2014 The Plan, Not the Stock, Is Driving It", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQN19LZGd5aG9RdlhRb2RCYkhRd1dRM3pjYkNRcmU2YVBIVmJ2ZmlYM2tJeW9WS0xjbElUaFBSNjNzVnZuZ0RqbnpJS3dJb2ViNGVCcVN3RGNYU01rVmFrRGZZeDIzNzM4N2x1bGd5dnhfMk9WOVNnVGJmT1FRWVRtNnJNUFlDNklhcGNhQV9TLV8xN0pCSFc2aHZCQjd4bFBWa1E?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iradimed-insider-sold-shares-worth-191437499.html", "source_name": "MT Newswires", "published_at": "2026-05-28T19:14:37+00:00", "published_display": "28 May 2026 19:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iradimed-corp-irmd-3-things-211840103.html", "source_name": "Insider Monkey", "published_at": "2026-05-27T21:18:40+00:00", "published_display": "27 May 2026 21:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed\u2019s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?", "summary": "", "url": "https://finance.yahoo.com/m/a39c76f4-839d-3131-a2e4-4e5106c5e9d2/iradimed%E2%80%99s-ceo-and-founder.html", "source_name": "Motley Fool", "published_at": "2026-05-26T01:02:55+00:00", "published_display": "26 May 2026 01:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/iradimed-corporation-present-goldman-sachs-123000196.html", "source_name": "GlobeNewswire", "published_at": "2026-05-20T12:30:00+00:00", "published_display": "20 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED CEO and CFO head to Goldman Sachs health conference in Miami", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQSFEyeWUxWDdNMHd6U1k5aWFPV3BBVjFhQ0tfSmlRMGVmVXYwTWdxNkk4TnJhaVpsSDVVLUpiWFBxN2tweUFwTVNhaHJ4d2dOTjgtcXVmWndfaS1EaHFNYl9xMzVUVDdRQXduM0pfZDVBMzlWdDNyZHpwQkNzVllFWV9ZeDlMTm5ycS1rVmJtVmtBRzFKZkQzSmhHU0NKTWp3a0xwTXhHbVZ6RkNQdmRJTzdkZzR4Sk5ZWXpr?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/heres-iradimeds-nasdaq-irmd-upcoming-121418231.html", "source_name": "Simply Wall St.", "published_at": "2026-05-11T12:14:18+00:00", "published_display": "11 May 2026 12:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 Guidance - Learn Why", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNWllmbWkwMFE2RFlobGRnSmZnM1gtY2ttdWVwNUhtcW9fcTFUb3hMTWt1YnZJRE9aN3VRSXRoWFlWOTc4VnRTeDJKMEpjcFp2dXNBLUhYRkJna1NkNVpfR2JXZERZeUE4TUpHaFdtVEJEVVFqVjNaQ0V6RnpOajVyMlhxbFJGbzJPSjRuNFAwQWFBdjc0SEdoZTdhN25jcDg?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED ($IRMD) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNLUNIWjVjVXFWbWlObzFIeWNaZ0VQcHVYRmFpbklFNjZlR1FvNGdGby00dVUwbnA1TlUzUG1hMWp6UUFKUUJ1Z3poRDRFQVVXOG01U3Ria1FjSEVYRUR6SkRfS0V0NnNWWlk3dW5VRFFLRTduSmcteUlfanIxS2FkYQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Iradimed Stock Topped the Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdFBERHVZQndiV2FnWm91S2hJUUtBN1JFbnFWbml0bFZwR3llbjNaR0twSkVoMkxKWFVoT2pTeEJGd01hcWFQOG42SzFGekR3WV84dUE2MHFHeE5hTnlveXNUd203N3RsNUxpR2xXWGJIVjB3V3RSZUIzTkFvY2xEdk9NSmlqcEhGaXdVZWZSUEtTTU92eHpOazlwUHp3UQ?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNZENzV3l1QTlNN2dueVRmMzJVa2hzR3YxaEVrYndfVkRnYWQ4cThpcDZ6ZWk0XzR3STd0UXlua0c0RW9tTHd0TDdITFgzTzJEbndqMkhBeFNfVDJrcF9SREt1aUNELUN1ZjdRS29yYmRaSkhvdTRPSnZuY1FEdFNxc285bEF5Qmx2VlBnSWVNanVWaFFRdmhZSC1xa3dsa3BqOTdZ?oc=5", "source_name": "Market source", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "The total return for IRADIMED (NASDAQ:IRMD) investors has risen faster than earnings growth over the last five years", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD Stock Price and Chart \u2014 NASDAQ:IRMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1GQzVqamcwVXF5QmtmUi1DcjdCdzRoZlJXMW5wVk4tQXZMVlR1OVRvSkNiS0ZMYl9BQlJuQWxkVzdCRDU0RVRsVlV6WDZRMVNEd2hrcE11c0RDTXow?oc=5", "source_name": "TradingView", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Should You Think About Buying IRADIMED CORPORATION (NASDAQ:IRMD) Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQdmVmRTBxQ0Q5M1p3YkVXaUxONU9nNDQ0QVhQMnJyS3NOS2tWdF9aTFVod2RjMHBPZHhhelBybjUyRlJ0TVFCMmJXOVFEbmZZYWJza3lRX1k2Y1d0TGl3a0ZzMjRPZ3dJMXJyMHdOZ09pbmhKa05pM3lGX0dwdDFkRDkyamJQc0pfd0h3bGFFMnFvWUpmaHdjZnRxTDJlX1NYT0RhWmlpZU1HTGtu?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T12:26:37+00:00", "published_display": "13 Jul 2026 12:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision Trading with Iradimed Corporation (IRMD) Risk Zones", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOQXhqaFBMMk1iVmRkQnRVRDBibkRsWWpib1BkM2MzZUpaYmVVc1JiOGw5dTBIWF9xZWN0V3hnZHRZSUdnOFZqUVV0dmVnMmhySTRCUC1yYWFhZDJNOWpreVg3cGlVSXpDLVJzM2xNa1FjazlGUmszR2pqWTQ0UG9nLTh5YkNFLXZ0WlR6SFZfSUo1WjZPaWxjUzRvS0Y5Yk15TDIwYnFuSnloNjlSUVNFS0ktVVlkNGR0bnFkTXBKRUUzSjJhRmNMbVRNWnVTYnpFRF9JM0dB?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-07-08T06:38:01+00:00", "published_display": "08 Jul 2026 06:38", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of iRadimed Corporation \u2013 NASDAQ:IRMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNYy1NNFhnWVFWd1drYXVjcUU1Yk5qc2pQV3hSM1BnUjRzYldsdVhlVDhmOW81RlppcUE3VUdVVUdJSElRSWtxTHMtZGF5VFdLZkNKd0FJSDhtb0o2QmhLR2ZJOEpka1Nlc1VKdElEcTI0NkdVTjQ1MlZtNmN4SGw5X1N0OFNjdEtVRVZmUl9hd1BkOXBRMFk1eHBvblc?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T09:35:02+00:00", "published_display": "05 Jul 2026 09:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of IRadimed Corp. \u2013 LS:A118V4", "summary": "This article provides financial information for IRadimed Corp. (LS:A118V4), specifically focusing on its price-to-book forward ratio. It includes an overview of the company's financials on TradingView, such as market data provided by ICE Data Services and reference data from Fact", "url": "https://www.tradingview.com/symbols/LS-A118V4/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T09:10:28", "published_display": "05 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD - Iradimed Corp Latest SEC Filings", "summary": "This article provides the latest SEC filings and a comprehensive overview of Iradimed Corp (IRMD) financials and performance metrics. It details key financial figures such as market cap, income, sales, and various ratios, alongside stock performance, insider and institutional own", "url": "https://finviz.com/stock?t=IRMD&p=d&ty=lf&r=ytd&page=15", "source_name": "Finviz", "published_at": "2026-06-30T13:40:00", "published_display": "30 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of IRadimed Corp. \u2013 HAN:46K", "summary": "This article provides the \"Price to book forward\" metric for IRadimed Corp. (HAN:46K) trading on the Hannover Stock Exchange. It is a financial data point without further analysis or contextual information.", "url": "https://www.tradingview.com/symbols/HAN-46K/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T04:41:31", "published_display": "29 Jun 2026 04:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of IRadimed Corp. \u2013 HAN:46K", "summary": "This article presents the enterprise value to revenue forward for IRadimed Corp. (HAN:46K) as listed on the Hannover Stock Exchange. Although the article provides no specific numerical data, it frames the company's financial metric within the context of a stock exchange listing. ", "url": "https://www.tradingview.com/symbols/HAN-46K/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T13:39:36", "published_display": "28 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp. Actuals & Estimates (DUS:46K)", "summary": "This article provides an overview of IRadimed Corp. (DUS:46K) financial actuals and estimates, including income statement, balance sheet, and cash flow data. It covers analyst forecasts for the stock, historical price performance, upcoming earnings dates, and details on past earn", "url": "https://www.tradingview.com/symbols/DUS-46K/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-28T10:10:59", "published_display": "28 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "46K Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for IRadimed Corp. (46K) stock, based on analyst opinions. It includes details on maximum and minimum price estimates, past financial performance, upcoming earnings dates, dividend information, and company metrics like EBITDA and ", "url": "https://www.tradingview.com/symbols/FWB-46K/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T11:39:32", "published_display": "26 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp. Actuals & Estimates (NASDAQ:IRMD)", "summary": "This article provides an overview of iRadimed Corporation (NASDAQ: IRMD) including financial actuals, estimates, and analyst forecasts. It covers key metrics like current stock price, historical highs and lows, market capitalization, earnings, revenue, dividends, and volatility, ", "url": "https://www.tradingview.com/symbols/NASDAQ-IRMD/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:10:14", "published_display": "26 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed (NASDAQ: IRMD) investors approve directors, auditor and pay", "summary": "Iradimed Corporation's shareholders held their annual meeting, where they elected Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel, and James Hawkins to the board of directors. They also approved RSM US LLP as the independent auditor for the fiscal year ending December 31", "url": "https://www.stocktitan.net/sec-filings/IRMD/8-k-iradimed-corp-reports-material-event-44ff5640cf4a.html", "source_name": "Stock Titan", "published_at": "2026-06-24T14:39:52", "published_display": "24 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Iradimed Co For: 23 June By Investing.com", "summary": "This article from Investing.com is a regulatory filing update titled \"Form 4 Iradimed Co For: 23 June.\" It reports on the Form 4 filing for Iradimed Co (IRMD) made on June 23rd, 2026, indicating insider transactions for the company. The article contains the title, publication dat", "url": "https://au.investing.com/news/stock-market-news/form-4-iradimed-co-for-23-june-93CH-4500543", "source_name": "Investing.com Australia", "published_at": "2026-06-23T23:09:32", "published_display": "23 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED (IRMD) CFO converts RSUs to stock and uses 2,319 shares for taxes", "summary": "IRADIMED CFO John Glenn converted 5,796 restricted stock units (RSUs) into common shares on June 20, 2026. He then disposed of 2,319 shares to cover tax obligations, which was a tax-withholding transaction, not an open-market sale. Following these transactions, Glenn directly hol", "url": "https://www.stocktitan.net/sec-filings/IRMD/form-4-iradimed-corp-insider-trading-activity-165cd58b1d27.html", "source_name": "Stock Titan", "published_at": "2026-06-23T13:10:26", "published_display": "23 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED (IRMD) Stock Could Be 21.9% Undervalued on Its MRI Pump Upgrade Narrative", "summary": "IRADIMED (IRMD) is currently valued by one narrative as 21.9% undervalued at $92.20 per share, with a fair value target of $118, primarily due to the anticipated replacement cycle driven by its new 3870 MRI compatible IV pump. While this narrative projects significant revenue gro", "url": "https://www.sahmcapital.com/news/content/iradimed-irmd-stock-could-be-219-undervalued-on-its-mri-pump-upgrade-narrative-2026-06-22", "source_name": "Sahm", "published_at": "2026-06-22T00:10:04", "published_display": "22 Jun 2026 00:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD Technical Analysis & Stock Price Forecast", "summary": "The article provides a technical analysis and stock price forecast for IRadimed Corp (IRMD), indicating a \"Strong Buy\" consensus based on various technical indicators and moving averages. While some indicators like RSI are neutral or sell, the MACD and several moving averages sug", "url": "https://intellectia.ai/en/stock/IRMD/technical", "source_name": "Intellectia AI", "published_at": "2026-06-18T21:13:19", "published_display": "18 Jun 2026 21:13", "sentiment": "positive", "sentiment_pct": 76, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for IRadimed Corp (IRMD), indicating an earnings forecast score of 8.00 and ranking 66th in its industry. Analysts, based on 2 ratings, have an average price target of $99.00 with a \"Buy\" recommendation. The company's previous quarter EP", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T20:11:16", "published_display": "18 Jun 2026 20:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for IRadimed Corp (IRMD), highlighting its current risk assessment score of 7.77 and ranking within the Healthcare Equipment & Supplies industry. It details various risk metrics including beta, maximum drawdown, volatility, and Sharpe Ratio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-17T21:40:51", "published_display": "17 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides a detailed historical overview of IRadimed Corp's (IRMD) dividend payouts, including future declared dividends. It lists the dividend amount, record date, payment date, and ex-dividend date for various interim and final cash dividends. The report also notes ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T20:11:16", "published_display": "17 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of IRadimed Corp (IRMD), listing major individual and institutional holders. It provides a breakdown of shareholder types and traces institutional shareholding trends over several quarters. The data includes the proportion of shares ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T02:11:13", "published_display": "17 Jun 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for IRadimed Corp (IRMD), categorizing its revenue by business segments and geographical regions. As of April 6, 2024, the company's largest revenue contributors are MRI Compatible IV Infusion Pump Systems and MRI Compatible Pati", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T02:11:12", "published_display": "17 Jun 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Institutional Confidence", "summary": "IRadimed Corp (IRMD) has an institutional shareholding score of 5.00, placing it 109th in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 65.08%, a 13.11% increase quarter-over-quarter. James Simons is the largest institutional sharehold", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/sentiment", "source_name": "TradingKey", "published_at": "2026-06-16T20:09:14", "published_display": "16 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of IRadimed Corp (IRMD), focusing on its support and resistance levels, various technical indicators, and moving averages. As of June 16, 2026, IRMD's price momentum score is 7.36, and the stock is trading between resistance at $98.06 an", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/technical", "source_name": "TradingKey", "published_at": "2026-06-16T19:40:26", "published_display": "16 Jun 2026 19:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article provides a financial analysis of IRadimed Corp (IRMD), highlighting its strong financial health with a score of 9.60. The company ranks highly in its industry due to robust financial status, high operating efficiency, and significant year-over-year increases in reven", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irmd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-16T07:40:51", "published_display": "16 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of IRadimed Corp. \u2013 DUS:46K", "summary": "The article displays an overview of IRadimed Corp. (DUS:46K) on the TradingView platform, focusing on the number of shareholders. It includes sections for financial data, news, community insights, forecasts, and stock information, indicating a market closed status with no recent ", "url": "https://www.tradingview.com/symbols/DUS-46K/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-06-06T23:09:43", "published_display": "06 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD - Iradimed Corp Stock Price and Quote", "summary": "This page provides a comprehensive overview of Iradimed Corp (IRMD) stock, including its latest closing price, dollar and percentage changes, and various financial metrics such as market cap, income, sales, and P/E ratio. It also details dividend information, employee count, IPO ", "url": "https://finviz.com/stock?t=IRMD", "source_name": "Finviz", "published_at": "2026-06-05T15:10:28", "published_display": "05 Jun 2026 15:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed director sells $285,000 in company stock By Investing.com", "summary": "A director at IRADIMED CORP, Hilda Frederique Scharen-Guivel, sold 3,000 shares of company stock for $285,000 on June 4, 2026. This transaction occurred amidst a strong 52% return for IRMD stock over the past year, though InvestingPro's Fair Value analysis suggests the shares may", "url": "https://za.investing.com/news/insider-trading-news/iradimed-director-sells-285000-in-company-stock-93CH-4315160", "source_name": "Investing.com South Africa", "published_at": "2026-06-05T04:40:10", "published_display": "05 Jun 2026 04:40", "sentiment": "negative", "sentiment_pct": 33, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Hilda Scharen-guivel Sells 3,000 Shares of iRadimed Corp (IRMD)", "summary": "Hilda Scharen-guivel, a Director at iRadimed Corp (IRMD), sold 3,000 shares of the company on June 4, 2026, reducing her holdings to 5,598 shares. This sale contributes to a pattern of 41 insider sells and no buys over the past year. iRadimed Corp, trading at $95 per share, is co", "url": "https://www.gurufocus.com/news/8902377/insider-sell-hilda-scharenguivel-sells-3000-shares-of-iradimed-corp-irmd?mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-05T03:09:43", "published_display": "05 Jun 2026 03:09", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed Insider Sold Shares Worth $285,000, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iradimed-insider-sold-shares-worth-203258087.html", "source_name": "MT Newswires", "published_at": "2026-06-04T20:32:58+00:00", "published_display": "04 Jun 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED (IRMD) director sells 3,000 shares in open-market trades", "summary": "IRADIMED CORP director Hilda Frederique Scharen-Guivel sold 3,000 shares of Common Stock in open-market transactions for $95.00 per share on June 4, 2026. This transaction represents a net sale of $285,000 and is categorized as negative filing sentiment. The shares she still hold", "url": "https://www.stocktitan.net/sec-filings/IRMD/form-4-iradimed-corp-insider-trading-activity-9144089377e9.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:10:03", "published_display": "04 Jun 2026 20:10", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD (NASDAQ: IRMD) files notice to resell 285,000 common shares", "summary": "Iradimed Corp (IRMD) has filed a Form 144 notice with the SEC, indicating a proposed sale of 285,000 shares of common stock. The filing also notes that 12,783,035 shares were outstanding as of June 4, 2026, and references RSU vesting events in 2023 and 2024. This form serves as a", "url": "https://www.stocktitan.net/sec-filings/IRMD/144-iradimed-corp-sec-filing-49e31ce5f132.html", "source_name": "Stock Titan", "published_at": "2026-06-04T17:10:03", "published_display": "04 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOS1ZEUlNmRDFyOFZma2NzQk1Sa1VaSk43a2xZOTRQNl9FT3o1OWhtRXQzWHpyVzZSaTFVeUF0eXpJMXZGOU8xbmtIUC14SGRTemhHM0F4aXdWclBqT012ZHRFMkJkcmRjWHJBcVFCczR1WTc1M1NHeDZGWEdMVHQ0YmlMZGZFWTJiTWxlU1hVekFTQ2tubUQtd3FrX25UVDlpVnBDc3dKTXY?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares", "summary": "IRADIMED CORP (NASDAQ:IRMD) CEO Roger E. Susi sold 2,500 shares of common stock totaling $226,507 on June 1, 2026, through the Phillip Susi 2008 Dynasty Trust under a Rule 10b5-1 trading plan. These sales occurred after a strong 61.5% return for IRMD stock and follow the company'", "url": "https://m.investing.com/news/insider-trading-news/iradimed-corp-ceo-roger-susi-sells-226507-in-irmd-shares-93CH-4722722?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-02T18:39:54", "published_display": "02 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED (IRMD) CEO-linked trust sells 2,500 shares under 10b5-1 plan", "summary": "A trust linked to Roger E. Susi, CEO of IRADIMED (IRMD), indirectly sold 2,500 shares of common stock on June 1, 2026, under a pre-arranged Rule 10b5-1 trading plan. The shares were sold in multiple trades at weighted average prices between $88.68 and $91.91. After these transact", "url": "https://www.stocktitan.net/sec-filings/IRMD/form-4-iradimed-corp-insider-trading-activity-4269a0755465.html", "source_name": "Stock Titan", "published_at": "2026-06-02T18:39:54", "published_display": "02 Jun 2026 18:39", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED's CEO Is Selling Steadily \u2014 The Plan, Not the Stock, Is Driving It", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQN19LZGd5aG9RdlhRb2RCYkhRd1dRM3pjYkNRcmU2YVBIVmJ2ZmlYM2tJeW9WS0xjbElUaFBSNjNzVnZuZ0RqbnpJS3dJb2ViNGVCcVN3RGNYU01rVmFrRGZZeDIzNzM4N2x1bGd5dnhfMk9WOVNnVGJmT1FRWVRtNnJNUFlDNklhcGNhQV9TLV8xN0pCSFc2aHZCQjd4bFBWa1E?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iradimed-insider-sold-shares-worth-191437499.html", "source_name": "MT Newswires", "published_at": "2026-05-28T19:14:37+00:00", "published_display": "28 May 2026 19:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iradimed-corp-irmd-3-things-211840103.html", "source_name": "Insider Monkey", "published_at": "2026-05-27T21:18:40+00:00", "published_display": "27 May 2026 21:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iradimed\u2019s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?", "summary": "", "url": "https://finance.yahoo.com/m/a39c76f4-839d-3131-a2e4-4e5106c5e9d2/iradimed%E2%80%99s-ceo-and-founder.html", "source_name": "Motley Fool", "published_at": "2026-05-26T01:02:55+00:00", "published_display": "26 May 2026 01:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/iradimed-corporation-present-goldman-sachs-123000196.html", "source_name": "GlobeNewswire", "published_at": "2026-05-20T12:30:00+00:00", "published_display": "20 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED CEO and CFO head to Goldman Sachs health conference in Miami", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQSFEyeWUxWDdNMHd6U1k5aWFPV3BBVjFhQ0tfSmlRMGVmVXYwTWdxNkk4TnJhaVpsSDVVLUpiWFBxN2tweUFwTVNhaHJ4d2dOTjgtcXVmWndfaS1EaHFNYl9xMzVUVDdRQXduM0pfZDVBMzlWdDNyZHpwQkNzVllFWV9ZeDlMTm5ycS1rVmJtVmtBRzFKZkQzSmhHU0NKTWp3a0xwTXhHbVZ6RkNQdmRJTzdkZzR4Sk5ZWXpr?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/heres-iradimeds-nasdaq-irmd-upcoming-121418231.html", "source_name": "Simply Wall St.", "published_at": "2026-05-11T12:14:18+00:00", "published_display": "11 May 2026 12:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 Guidance - Learn Why", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNWllmbWkwMFE2RFlobGRnSmZnM1gtY2ttdWVwNUhtcW9fcTFUb3hMTWt1YnZJRE9aN3VRSXRoWFlWOTc4VnRTeDJKMEpjcFp2dXNBLUhYRkJna1NkNVpfR2JXZERZeUE4TUpHaFdtVEJEVVFqVjNaQ0V6RnpOajVyMlhxbFJGbzJPSjRuNFAwQWFBdjc0SEdoZTdhN25jcDg?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRADIMED ($IRMD) Releases Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNLUNIWjVjVXFWbWlObzFIeWNaZ0VQcHVYRmFpbklFNjZlR1FvNGdGby00dVUwbnA1TlUzUG1hMWp6UUFKUUJ1Z3poRDRFQVVXOG01U3Ria1FjSEVYRUR6SkRfS0V0NnNWWlk3dW5VRFFLRTduSmcteUlfanIxS2FkYQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Iradimed Stock Topped the Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdFBERHVZQndiV2FnWm91S2hJUUtBN1JFbnFWbml0bFZwR3llbjNaR0twSkVoMkxKWFVoT2pTeEJGd01hcWFQOG42SzFGekR3WV84dUE2MHFHeE5hTnlveXNUd203N3RsNUxpR2xXWGJIVjB3V3RSZUIzTkFvY2xEdk9NSmlqcEhGaXdVZWZSUEtTTU92eHpOazlwUHp3UQ?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNZENzV3l1QTlNN2dueVRmMzJVa2hzR3YxaEVrYndfVkRnYWQ4cThpcDZ6ZWk0XzR3STd0UXlua0c0RW9tTHd0TDdITFgzTzJEbndqMkhBeFNfVDJrcF9SREt1aUNELUN1ZjdRS29yYmRaSkhvdTRPSnZuY1FEdFNxc285bEF5Qmx2VlBnSWVNanVWaFFRdmhZSC1xa3dsa3BqOTdZ?oc=5", "source_name": "Market source", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The total return for IRADIMED (NASDAQ:IRMD) investors has risen faster than earnings growth over the last five years", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRMD Stock Price and Chart \u2014 NASDAQ:IRMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1GQzVqamcwVXF5QmtmUi1DcjdCdzRoZlJXMW5wVk4tQXZMVlR1OVRvSkNiS0ZMYl9BQlJuQWxkVzdCRDU0RVRsVlV6WDZRMVNEd2hrcE11c0RDTXow?oc=5", "source_name": "TradingView", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 91, "total_relevant": 57, "sentiment_summary": {"positive": 10, "negative": 7, "neutral": 40, "score": 52, "total": 57, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 17.6, "count": 32}, {"event": "earnings", "label": "Earnings", "weight": 8.52, "count": 18}, {"event": "capital_return", "label": "Capital return", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 97.2, "latest_week": "2026-07-10", "one_week_move": -3.7, "four_week_move": 3.8, "twelve_week_move": 4.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.105761, "market_dynamics_buy_signal": false, "relative_strength": -3.670601, "fair_value_gap": 61.2, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 59.4741, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.7% over one week, +3.8% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 13}, {"label": "TradingView", "count": 9}, {"label": "TradingKey", "count": 8}, {"label": "Stock Titan", "count": 6}, {"label": "Finviz", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "MT Newswires", "count": 2}, {"label": "simplywall.st", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 47}, {"label": "Industry context", "count": 10}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 32}, {"label": "Earnings", "count": 18}, {"label": "Capital return", "count": 3}, {"label": "Analyst action", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "47", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.7% over one week, +3.8% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Should You Think About Buying IRADIMED CORPORATION (NASDAQ:IRMD) Now?"}], "updated_at": "2026-07-17T22:21:08.751003+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}